Grok 2: Growth ETFs
Asset Allocation
Position | Category/Sector | Target Weight |
---|---|---|
AMZN Amazon.com, Inc. | Consumer Cyclical | 10% |
ATRA Atara Biotherapeutics, Inc. | Healthcare | 10% |
BLND Blend Labs, Inc. | Technology | 10% |
CRM salesforce.com, inc. | Technology | 10% |
MSFT Microsoft Corporation | Technology | 10% |
NRG NRG Energy, Inc. | Utilities | 10% |
OKTA Okta, Inc. | Technology | 10% |
RIGL Rigel Pharmaceuticals, Inc. | Healthcare | 10% |
TSLA Tesla, Inc. | Consumer Cyclical | 10% |
TVTX Travere Therapeutics, Inc. | Healthcare | 10% |
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Grok 2: Growth ETFs, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is never rebalanced.
The earliest data available for this chart is Jul 16, 2021, corresponding to the inception date of BLND
Returns By Period
YTD | 1M | 6M | 1Y | 5Y* | 10Y* | |
---|---|---|---|---|---|---|
^GSPC S&P 500 | -10.18% | -6.79% | -9.92% | 6.35% | 14.12% | 9.63% |
Grok 2: Growth ETFs | -14.13% | -10.19% | -1.37% | 25.62% | N/A | N/A |
Portfolio components: | ||||||
RIGL Rigel Pharmaceuticals, Inc. | 0.18% | -16.58% | 11.52% | 56.02% | 2.09% | -9.03% |
BLND Blend Labs, Inc. | -26.13% | -14.79% | -13.61% | 33.48% | N/A | N/A |
TVTX Travere Therapeutics, Inc. | -14.35% | -27.33% | -16.51% | 160.84% | -0.07% | -4.95% |
ATRA Atara Biotherapeutics, Inc. | -53.64% | -6.94% | -34.43% | -62.66% | -50.27% | -42.74% |
OKTA Okta, Inc. | 24.28% | -13.90% | 30.89% | 6.41% | -8.01% | N/A |
TSLA Tesla, Inc. | -40.23% | -2.95% | 9.37% | 64.14% | 39.63% | 32.53% |
CRM salesforce.com, inc. | -25.93% | -11.75% | -15.36% | -8.01% | 10.63% | 13.83% |
AMZN Amazon.com, Inc. | -21.32% | -12.03% | -8.67% | -1.16% | 8.23% | 24.45% |
MSFT Microsoft Corporation | -12.57% | -6.00% | -11.70% | -7.15% | 18.10% | 25.77% |
NRG NRG Energy, Inc. | 8.94% | -2.78% | 14.36% | 42.65% | 30.78% | 17.49% |
Monthly Returns
The table below presents the monthly returns of Grok 2: Growth ETFs, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025 | 7.64% | -6.53% | -9.89% | -5.28% | -14.13% | ||||||||
2024 | -2.09% | 7.12% | 3.24% | -5.60% | 3.55% | 4.03% | 1.63% | 1.95% | 11.23% | 0.97% | 17.41% | -3.27% | 45.52% |
2023 | 15.39% | -1.29% | 4.80% | -4.94% | 4.07% | 1.68% | 5.20% | -5.18% | -8.54% | -5.31% | 13.14% | 9.35% | 28.32% |
2022 | -8.17% | -4.89% | -1.16% | -15.12% | -6.94% | -4.77% | 4.31% | 1.56% | -10.01% | -3.43% | -5.41% | -9.47% | -48.81% |
2021 | -0.87% | 10.78% | -0.40% | 9.18% | -3.05% | -2.24% | 13.17% |
Expense Ratio
Grok 2: Growth ETFs has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of Grok 2: Growth ETFs is 64, indicating average performance compared to other portfolios on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
This table presents a comparison of risk-adjusted performance metrics for positions. Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Martin ratio | |
---|---|---|---|---|---|
RIGL Rigel Pharmaceuticals, Inc. | 0.55 | 1.51 | 1.18 | 0.58 | 2.15 |
BLND Blend Labs, Inc. | 0.41 | 1.21 | 1.14 | 0.34 | 1.44 |
TVTX Travere Therapeutics, Inc. | 2.24 | 2.92 | 1.34 | 1.72 | 12.01 |
ATRA Atara Biotherapeutics, Inc. | -0.55 | -0.39 | 0.95 | -0.64 | -1.34 |
OKTA Okta, Inc. | 0.07 | 0.45 | 1.06 | 0.04 | 0.18 |
TSLA Tesla, Inc. | 0.73 | 1.55 | 1.18 | 0.82 | 2.47 |
CRM salesforce.com, inc. | -0.27 | -0.13 | 0.98 | -0.30 | -0.78 |
AMZN Amazon.com, Inc. | -0.18 | -0.02 | 1.00 | -0.20 | -0.58 |
MSFT Microsoft Corporation | -0.43 | -0.46 | 0.94 | -0.45 | -1.04 |
NRG NRG Energy, Inc. | 0.70 | 1.23 | 1.16 | 1.29 | 3.79 |
Dividends
Dividend yield
Grok 2: Growth ETFs provided a 0.32% dividend yield over the last twelve months.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Portfolio | 0.32% | 0.30% | 0.37% | 0.55% | 0.37% | 0.41% | 0.15% | 0.20% | 0.23% | 0.43% | 0.73% | 0.45% |
Portfolio components: | ||||||||||||
RIGL Rigel Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BLND Blend Labs, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
TVTX Travere Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ATRA Atara Biotherapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
OKTA Okta, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
TSLA Tesla, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CRM salesforce.com, inc. | 0.65% | 0.48% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
AMZN Amazon.com, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MSFT Microsoft Corporation | 0.86% | 0.73% | 0.74% | 1.06% | 0.68% | 0.94% | 1.20% | 1.69% | 1.86% | 2.37% | 2.33% | 2.48% |
NRG NRG Energy, Inc. | 1.70% | 1.81% | 2.92% | 4.40% | 3.02% | 3.20% | 0.30% | 0.30% | 0.42% | 1.92% | 4.93% | 2.00% |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Grok 2: Growth ETFs. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Grok 2: Growth ETFs was 56.67%, occurring on Dec 27, 2022. The portfolio has not yet recovered.
The current Grok 2: Growth ETFs drawdown is 26.74%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-56.67% | Nov 5, 2021 | 287 | Dec 27, 2022 | — | — | — |
-4.11% | Sep 24, 2021 | 7 | Oct 4, 2021 | 13 | Oct 21, 2021 | 20 |
-3.82% | Sep 3, 2021 | 11 | Sep 20, 2021 | 3 | Sep 23, 2021 | 14 |
-2.07% | Jul 19, 2021 | 1 | Jul 19, 2021 | 7 | Jul 28, 2021 | 8 |
-1.63% | Aug 6, 2021 | 3 | Aug 10, 2021 | 2 | Aug 12, 2021 | 5 |
Volatility
Volatility Chart
The current Grok 2: Growth ETFs volatility is 17.54%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Diversification
Asset Correlations Table
NRG | RIGL | TVTX | BLND | ATRA | TSLA | MSFT | OKTA | AMZN | CRM | |
---|---|---|---|---|---|---|---|---|---|---|
NRG | 1.00 | 0.20 | 0.22 | 0.17 | 0.16 | 0.23 | 0.33 | 0.25 | 0.31 | 0.32 |
RIGL | 0.20 | 1.00 | 0.40 | 0.24 | 0.35 | 0.23 | 0.22 | 0.31 | 0.25 | 0.28 |
TVTX | 0.22 | 0.40 | 1.00 | 0.25 | 0.37 | 0.24 | 0.24 | 0.30 | 0.24 | 0.28 |
BLND | 0.17 | 0.24 | 0.25 | 1.00 | 0.23 | 0.32 | 0.27 | 0.41 | 0.32 | 0.35 |
ATRA | 0.16 | 0.35 | 0.37 | 0.23 | 1.00 | 0.30 | 0.27 | 0.32 | 0.30 | 0.28 |
TSLA | 0.23 | 0.23 | 0.24 | 0.32 | 0.30 | 1.00 | 0.46 | 0.42 | 0.48 | 0.44 |
MSFT | 0.33 | 0.22 | 0.24 | 0.27 | 0.27 | 0.46 | 1.00 | 0.50 | 0.71 | 0.60 |
OKTA | 0.25 | 0.31 | 0.30 | 0.41 | 0.32 | 0.42 | 0.50 | 1.00 | 0.54 | 0.61 |
AMZN | 0.31 | 0.25 | 0.24 | 0.32 | 0.30 | 0.48 | 0.71 | 0.54 | 1.00 | 0.61 |
CRM | 0.32 | 0.28 | 0.28 | 0.35 | 0.28 | 0.44 | 0.60 | 0.61 | 0.61 | 1.00 |